🟢 Icecure Medical is trading 7.1% up in after-hours trading; no clear company-specific catalyst identified

Icecure Medical is trading 7.1% up at $1.65 after closing at $1.54 on October 5, with no clear company-specific catalyst identified for the after-hours move.

• The company’s official press-release page lists its latest release as September 10, announcing Chinese regulatory approval for ProSense; it shows no October 5 announcement.
• The broader market was positive, but available evidence does not establish that market sentiment drove the move.